ATE399159T1 - Silanester und silaneamide von 2-oxothiazolidin-4-carbonsäureamide und deren verwendung zur vorbeugung der lichtbedingten hautalterung - Google Patents

Silanester und silaneamide von 2-oxothiazolidin-4-carbonsäureamide und deren verwendung zur vorbeugung der lichtbedingten hautalterung

Info

Publication number
ATE399159T1
ATE399159T1 AT05802359T AT05802359T ATE399159T1 AT E399159 T1 ATE399159 T1 AT E399159T1 AT 05802359 T AT05802359 T AT 05802359T AT 05802359 T AT05802359 T AT 05802359T AT E399159 T1 ATE399159 T1 AT E399159T1
Authority
AT
Austria
Prior art keywords
silanesters
silaneamids
oxothiazolidine
preventing
carbonic acid
Prior art date
Application number
AT05802359T
Other languages
English (en)
Inventor
Karine Lucet-Levannier
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE399159T1 publication Critical patent/ATE399159T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
AT05802359T 2004-10-21 2005-09-27 Silanester und silaneamide von 2-oxothiazolidin-4-carbonsäureamide und deren verwendung zur vorbeugung der lichtbedingten hautalterung ATE399159T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0452399A FR2877004B1 (fr) 2004-10-21 2004-10-21 Esters et amides silaniques d'acide 2-oxothiazolidine-4- carboxylique et leurs utilisations cosmetiques.
US63254104P 2004-12-03 2004-12-03

Publications (1)

Publication Number Publication Date
ATE399159T1 true ATE399159T1 (de) 2008-07-15

Family

ID=34950806

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05802359T ATE399159T1 (de) 2004-10-21 2005-09-27 Silanester und silaneamide von 2-oxothiazolidin-4-carbonsäureamide und deren verwendung zur vorbeugung der lichtbedingten hautalterung

Country Status (8)

Country Link
US (1) US7795286B2 (de)
EP (1) EP1805153B1 (de)
JP (1) JP5149011B2 (de)
AT (1) ATE399159T1 (de)
DE (1) DE602005007764D1 (de)
ES (1) ES2308565T3 (de)
FR (1) FR2877004B1 (de)
WO (1) WO2006045639A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3556401A1 (de) 2005-05-27 2019-10-23 The University of North Carolina at Chapel Hill Stickoxidfreisetzende partikel für stickoxidtherapeutika und biomedizinische anwendungen
JP2009525948A (ja) * 2005-12-20 2009-07-16 シラメッド・インコーポレーテッド 高親油性スルフヒドリル化合物の製薬組成物及び使用方法
FR2921257B1 (fr) * 2007-09-21 2009-11-06 Exsymol Sa Utilisation topique de derives thiazolidines contre les consequences du stress oxydatif de la peau
FR2940615B1 (fr) 2008-12-30 2011-12-30 Oreal Association de monosaccharides avec des agents antioxydants et son utilisation en cosmetique
WO2011022652A1 (en) 2009-08-21 2011-02-24 Novan, Inc. Topical gels
US9919072B2 (en) 2009-08-21 2018-03-20 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
AU2011227198A1 (en) * 2010-03-17 2012-10-04 Arbonne International Llc Topical skin care composition
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
EP2681286B1 (de) 2011-02-28 2018-08-15 Novan, Inc. Stickoxid-freisetzende s-nitrosothiol-modifizierte kieselsäureteilchen und verfahren zu ihrer herstellung
US9132725B2 (en) 2011-05-09 2015-09-15 Cummins Inc. Vehicle and hybrid drive system
US10239847B1 (en) 2016-03-03 2019-03-26 Cellactin Method for 2-oxothiazolidine-4-carboxylic acid for cellular glutathione
JP7118591B2 (ja) 2017-02-28 2022-08-16 ロレアル レゾルシノール又はその誘導体を含む組成物
JP7412898B2 (ja) 2019-04-26 2024-01-15 ロレアル 特異な粒子と親油性抗酸化剤との組み合わせ
JP2021095354A (ja) 2019-12-16 2021-06-24 ロレアル 特定の成分の組合せを含む安定な組成物
FR3131837A1 (fr) 2022-01-19 2023-07-21 L'oreal Composition stable comprenant un rétinoïde et un composé acide ascorbique
WO2023120390A1 (en) 2021-12-20 2023-06-29 L'oreal Stable composition comprising retinoid and ascorbic acid compound
WO2023120259A1 (en) 2021-12-20 2023-06-29 Oreal Stable composition comprising retinoid
FR3131845A1 (fr) 2022-01-19 2023-07-21 L'oreal Composition stable comprenant un rétinoïde

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208249A (en) * 1992-08-20 1993-05-04 Clintec Nutrition Co. Method for stimulating intracellular synthesis of glutathione using esters of L-2-oxothiazolidine-4-carboxylate
FR2854160B1 (fr) * 2003-04-25 2005-06-17 Oreal Nouveaux derives heterocycliques de l'acide 2-oxothiazolidine4-carboxylique, utilisation comme agent de photoprotection active

Also Published As

Publication number Publication date
FR2877004A1 (fr) 2006-04-28
EP1805153B1 (de) 2008-06-25
EP1805153A1 (de) 2007-07-11
ES2308565T3 (es) 2008-12-01
DE602005007764D1 (de) 2008-08-07
JP2008517030A (ja) 2008-05-22
FR2877004B1 (fr) 2007-03-09
US7795286B2 (en) 2010-09-14
JP5149011B2 (ja) 2013-02-20
WO2006045639A1 (en) 2006-05-04
US20090074682A1 (en) 2009-03-19

Similar Documents

Publication Publication Date Title
ATE399159T1 (de) Silanester und silaneamide von 2-oxothiazolidin-4-carbonsäureamide und deren verwendung zur vorbeugung der lichtbedingten hautalterung
DK1214936T3 (da) Anvendelse af thiazolidin- eller pyrrolidinderivater af aminosyrer som antihyperglykæmiske midler
AR038379A1 (es) Esteres de acidos fluoreno-carboxilicos, procedimientos para su preparacion asi como su utilizacion en calidad de medicamentos
CO5611113A2 (es) Tripeptidos que poseen un eter de hidroxiprolina de una quinolina sustituida para la inhibicion de ns3 (hepatitis c)
DE10190550D2 (de) Kosmetische Zusammensetzung
ATE359268T1 (de) Derivate von n-(phenyl(alkylpiperidin-2- yl)methyl)benzamid, verfahren zu deren herstellung und deren anwendung in therapeutika
ATE461259T1 (de) Flüssigkristallines medium mit monofluor- terphenylverbindungen
UY29388A1 (es) Derivados del (1,5-difenil-h-pirazol-3-il)oxadiazol, su preparación y su aplicacion en terapéutica.
AR047085A1 (es) Derivados de (3-oxo-3,4-dihidro-quinoxalina-2-il-amino)benzamida y compuestos relacionados como inhibidores de glucogeno fosforilasa para el tratamiento de diabetes y obesidad
DE502004004294D1 (de) Verfahren zur herstellung von pyrrolidin-1,2-dicarbonsäure-1 -(phenyl(-amid))-2-(phenyl(-amid)) derivaten und 1-(phenylcarbamoyl)-pyrrolidin-2-carbonsäurederivate als zwischenprodukte
AR049770A1 (es) Derivados de piperidina como moduladores de la actividad de quimioquinas
RU2008105304A (ru) Соединение бензоимидазола, способное к ингибированию простагландин-d-синтетазы
ATE510569T1 (de) Verwendung von gelatine und einem vernetzungsmittel zur herstellung einer vernetzenden therapeutischen zusammensetzung
ATE432690T1 (de) Formel für injizierbares flüssiges paracetamol
ES555992A0 (es) Procedimiento para la obtencion de e-isomeros de derivados y peptidos de n<-(2-ciano-2-alcoximino-acetil)-aminoacidos
IT1311791B1 (it) Nastro flessibile a bolle, particolarmente per imballaggi e metodo perla sua realizzazione.
ATE493110T1 (de) Kosmetische zusammensetzung zur stimulierung der synthese der proteine der basalmembran
ECSP078009A (es) Derivados del 4,5-diarilpirrol, su preparación y su aplicación en terapéutica
NI200600270A (es) Una composición farmacéutica antimicobacteriana que comprende un farmaco antituberculosis
ES472448A1 (es) Procedimiento para la preparacion de nuevas amidas de acidosn-i-(3-benzoilpropil)-4-piperidil)-sulfonicos.
BRPI0513257C1 (pt) composição farmacêutica líquida de derivados de piperazina
ECSP099339A (es) Derivados de pirrol, su preparación y su utilización en terapéutica
ECSP056231A (es) Fluorbutenos nematicidas que contienen tiazolina
ATE336901T1 (de) Verwendung eines akariziden pulvers
CY1109050T1 (el) Μεθοδος σταθεροποιησης πρωτεϊνων σε συμπλοκα μιγματα κατα την αποθηκευση τους σε υδατικους διαλυτες

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties